SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Doc Bones who wrote (10473)2/18/2004 11:43:09 AM
From: Biomaven  Read Replies (2) of 52153
 
Welcome news today on Antegren.

But the relative price performance of the two companies involved is interesting. Coincidentally, ELN and BIIB have about the same number of shares outstanding. But BIIB went up $9 and ELN went up $2.25.

In fact, in my view ELN should by rights go up a little more in total dollar terms than BIIB simply because ELN's finances are still a little cloudy and this removes some risk from the stock.

Wonder if BIIB is thinking about munching ELN?

(I own ELN but not BIIB).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News